Who Paid My Doc
Joseph Chang
Ophthalmic Plastic and Reconstructive Surgery Bakersfield, CA Medical Doctor
NPI 1306959259 CMS profile 194856
4101 Empire Drive, Suite 120, Bakersfield, CA 93309
General payments
$74,448
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Joseph Chang of Bakersfield, CA is reported in the CMS Open Payments database as having received $74,448 across 134 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 92nd percentile of Ophthalmic Plastic and Reconstructive Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $118 | 5 | |
| 2024 | General | $283 | 4 | |
| 2023 | General | $10,017 | 18 | |
| 2022 | General | $12,818 | 13 | |
| 2021 | General | $11,767 | 24 | |
| 2020 | General | $11,402 | 24 | |
| 2019 | General | $28,042 | 46 |
Beside peers
- Joseph Chang
- Ophthalmic Plastic and Reconstructive Surgery median
- Middle half of Ophthalmic Plastic and Reconstructive Surgery
- National median
In program year 2025, general payments to Joseph Chang were reported at $118. Among 325 Ophthalmic Plastic and Reconstructive Surgery profiles paid that year, the median was $298 and the middle half received between $132 and $820.
Show as a table
| Year | Joseph Chang | Ophthalmic Plastic and Reconstructive Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $28,042 | $182 | $73–$467 | $163 |
| 2020 | $11,402 | $125 | $41–$412 | $114 |
| 2021 | $11,767 | $173 | $52–$538 | $132 |
| 2022 | $12,818 | $237 | $78–$809 | $149 |
| 2023 | $10,017 | $291 | $103–$776 | $160 |
| 2024 | $283 | $304 | $108–$822 | $164 |
| 2025 | $118 | $298 | $132–$820 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
134 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Ophthalmic Plastic and Reconstructive Surgery in California
Marjan Farid
Ophthalmic Plastic and Reconstructive Surgery · Irvine, CA
Jeffrey Joseph
Ophthalmic Plastic and Reconstructive Surgery · Newport Beach, CA
Sandy Zhang-Nunes
Ophthalmic Plastic and Reconstructive Surgery · Los Angeles, CA
Soheab Ugradar
Ophthalmic Plastic and Reconstructive Surgery · Los Angeles, CA
Andrea Kossler
Ophthalmic Plastic and Reconstructive Surgery · Stanford, CA
Nicolas Biro
Ophthalmic Plastic and Reconstructive Surgery · West Covina, CA
Related records
Ophthalmic Plastic and Reconstructive Surgery in California
Practitioners in the same specialty and state, ranked by reported value.
All Ophthalmic Plastic and Reconstructive Surgery
Everyone recorded under this specialty, nationwide.
Doctors in California
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.